Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study
Open Access
- 1 October 2002
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 15 (9-10) , 463-471
Abstract
Various immunosuppressive regiments aim to reduce the incidence of acute rejection after liver transplantation. The efficacy of antithymocyte globulin (ATG) induction therapy and short‐term effects on the cellular response have been demonstrated in several studies. Nevertheless, information about long‐term effects of ATG therapy on cellular responses and frequency of complications is limited. Therefore, we analyzed the effect of ATG administration within a cyclosporine‐based induction therapy, including azathioprine and prednisolone, on lymphocyte subsets and activation markers. We divided 35 liver transplant recipients into two groups according to their initial postoperative immunosuppression: a triple group without (n= 15) and a quadruple group with ATG (n= 20). The minimum observation time (flow cytometry analysis, clinical follow‐up) was 2 years. Patients treated with ATG had persistently lower percentages of T cells for at least 2 years postoperatively (PP+ T cells within 2 years (P+ and HLA‐DR+ T cells was temporarily higher in patients with ATG treatment (P+/CD57+ double positive cells in the late postoperative phase (P<0.05). In contrast, no differences could be observed between the two groups for major parameters of clinical outcome (acute rejections, servere infections, patient survival). We conclude that ATG therapy induces long‐lasting alterations in T‐cell subset composition. However, no beneficial clinical effect could be confirmed after liver transplantation.Keywords
This publication has 35 references indexed in Scilit:
- EXPERIENCE WITH DACLIZUMAB IN LIVER TRANSPLANTATIONTransplantation, 2000
- Predicting outcome after liver transplantationLiver Transplantation and Surgery, 1999
- Persistent Long-Term Changes In Lymphocyte Subsets Induced By Polyclonal Antibodies1Transplantation, 1997
- A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-2 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1997
- Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantationTransplant International, 1996
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejectionTransplant International, 1993
- T-Lymphocyte-Antigen Interactions in Transplant RejectionNew England Journal of Medicine, 1990
- Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effectBritish Journal of Haematology, 1988
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979